Literature DB >> 9950102

Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.

T Ebina1, Y Fujimiya.   

Abstract

The antitumor effect of extracts obtained from the fruit body of Agaricus blazei Murill was examined in a double-grafted tumor system, in which BALB/c mice received simultaneous intradermal injections of Meth-A tumor cells in both the right (10(6) cells) and left flank (2 x 10(5) cells), and were then injected with 5 mg of extracts of A. blazei in the right tumor on days 3, 4 and 5. Intratumoral administration of ethanol-soluble (Fraction 1), water-ethanol-soluble (Fraction 2), ammonium oxalate-soluble (Fraction 3) and ammonium oxalate-insoluble (Fraction 4) fractions resulted in inhibition of tumor growth, with Fraction 3 showing the most tumoricidal activity, producing regression of the right tumor and inhibition of growth of the left, non-injected tumor. The maximum effect was obtained using 0.5 mg of Fraction 3 and this amount was used in subsequent experiments. The antitumor effect of intratumorally administered Fraction 3 was enhanced by oral ad lib administration of feed containing 0.083% of Fraction 3. When immunized spleen cells from mice that had been cured by intratumoral administration of 0.5 mg of Fraction 3 were directly injected (2 x 10(7) cells/mouse) into the Meth-A tumor, tumor growth was inhibited. The tumor cells on day 7 from the Fraction 3-treated right tumor and from the left tumor were cultured for 24 h and their culture supernatants were assayed for neutrophil or macrophage chemotactic activity. Significant macrophage chemotactic factor activity was detected in the culture media from the left tumor tissue. Serum levels of immunosuppressive acidic protein (IAP), produced by activated macrophages and neutrophils, increased transiently soon after intradermal injection of 0.5 mg of Fraction 3. These results suggest that regression of the left non-injected tumor was due to an immune reaction, involving induction of cytotoxic cells in the spleen, and the release of chemotactic factors in the distant tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9950102     DOI: 10.1023/a:1008054111445

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  12 in total

1.  An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro.

Authors:  Soosaipillai Bernardshaw; Geir Hetland; Linda Kathrine Ellertsen; Anne Merete Aaland Tryggestad; Egil Johnson
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

2.  Antithetical effects of hemicellulase-treated Agaricus blazei on the maturation of murine bone-marrow-derived dendritic cells.

Authors:  Masaki Kawamura; Hirotake Kasai; Limin He; Xuewen Deng; Atsuya Yamashita; Hiroshi Terunuma; Isao Horiuchi; Fuminori Tanabe; Masahiko Ito
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

3.  Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development.

Authors:  Juliana L Gonçalves; Eric H Roma; Ana Cristina Gomes-Santos; Edenil C Aguilar; Daniel Cisalpino; Luciana R Fernandes; Angélica T Vieira; Dirce R Oliveira; Valbert N Cardoso; Mauro M Teixeira; Jacqueline I Alvarez-Leite
Journal:  Eur J Nutr       Date:  2011-11-16       Impact factor: 5.614

4.  In vivo growth-inhibition of Sarcoma 180 by an alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill.

Authors:  Maria Leônia Costa Gonzaga; Daniel Pereira Bezerra; Ana Paula Negreiros Nunes Alves; Nylane Maria Nunes de Alencar; Rodney de Oliveira Mesquita; Michael Will Lima; Sandra de Aguiar Soares; Cláudia Pessoa; Manoel Odorico de Moraes; Letícia Veras Costa-Lotufo
Journal:  J Nat Med       Date:  2008-08-23       Impact factor: 2.343

5.  Immunomodulating compounds in Basidiomycetes.

Authors:  Masashi Mizuno; Yosuke Nishitani
Journal:  J Clin Biochem Nutr       Date:  2013-04-19       Impact factor: 3.114

6.  Oral Treatment with Extract of Agaricus blazei Murill Enhanced Th1 Response through Intestinal Epithelial Cells and Suppressed OVA-Sensitized Allergy in Mice.

Authors:  Go Bouike; Yosuke Nishitani; Hideyuki Shiomi; Masaru Yoshida; Takeshi Azuma; Takashi Hashimoto; Kazuki Kanazawa; Masashi Mizuno
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-26       Impact factor: 2.629

7.  The anti-tumorigenic mushroom Agaricus blazei Murill enhances IL-1β production and activates the NLRP3 inflammasome in human macrophages.

Authors:  Tsung-Teng Huang; David M Ojcius; John D Young; Yi-Hui Wu; Yun-Fei Ko; Tsui-Yin Wong; Cheng-Yeu Wu; Chia-Chen Lu; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems.

Authors:  F Firenzuoli; L Gori; G Lombardo
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

9.  Delayed Cell Cycle Progression and Apoptosis Induced by Hemicellulase-Treated Agaricus blazei.

Authors:  Masaki Kawamura; Hirotake Kasai
Journal:  Evid Based Complement Alternat Med       Date:  2006-09-11       Impact factor: 2.629

10.  Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer.

Authors:  James A Talcott; Jack A Clark; Insu P Lee
Journal:  BMC Complement Altern Med       Date:  2007-10-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.